Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide - A retrospective single-center study with a Japanese cohort

CONCLUSION: Our data suggest that a higher dose of CD34+ cells in haplo-PBSCT with PTCy positively impacts the outcomes without an increase of GVHD.PMID:38199143 | DOI:10.1016/j.bcmd.2023.102820

Source: Blood Cells, Molecules and Diseases - January 10, 2024 Category: Hematology Authors: Yumiko Maruyama Hidekazu Nishikii Naoki Kurita Tatsuhiro Sakamoto Keiichiro Hattori Yasuhito Suehara Yasuhisa Yokoyama Takayasu Kato Naoshi Obara Mamiko Sakata-Yanagimoto Shigeru Chiba Source Type: research